Manuela Callari

Manuela Callari

Dr Manuela Callari is a Sydney-based freelance science writer who specialises in health and medical stories.

  • A robotic hip exoskeleton for amputees

    Autonomous, powered hip exoskeleton could help with mobility for people with above-knee amputations.

    Researchers from the Department of Mechanical Engineering and Robotics Center at the University of Utah, US, have eng...

    October 12, 2021
  • How can Australia safely return to work after COVID lockdowns?

    Restrictions ease across Greater Sydney today, with many going back to work after over 100 days o...

    As New South Wales approaches the 80% double-dose target, restrictions will ease in the next few weeks, and most busi...

    October 11, 2021
  • Molnupiravir: A pill for COVID-19?

    A new antiviral drug is promising to reduce COVID-19 hospitalisations and deaths.

    On Tuesday, the federal government announced the purchase of 300,000 doses of molnupiravir, an oral antiviral drug be...

    October 7, 2021
  • How can we treat COVID-19?

    As Australia begins to reopen and moves away from COVID zero, we will increasingly have to rely o...

    The effect of high vaccination rates, particularly in New South Wales, is slowly becoming apparent. Daily cases are n...

    October 4, 2021
  • How to COVID-19-proof classrooms

    As the Delta variant continues to spread and governments plan school reopening, what research can...

    Children in Victoria and New South Wales will make a staggered return to face-to-face learning from the second half o...

    October 1, 2021
  • Rapid antigen tests coming to Australia

    They’re the fast and cheap COVID-testing alternative. How do they work and when should we use them?

    This article was originally published on 23 July 2021 and updated on 28 September 2021. Australians will soon be a...

    September 28, 2021
  • Pfizer COVID-19 vaccine could soon be approved for young children

    Phase 2/3 clinical trials in children show promising results.

    Pfizer/BioNTech have announced that their mRNA COVID-19 vaccine proved safe and effective in the phase 2/3 trials in ...

    September 23, 2021
  • Message in a bottle

    The potential of mRNA technology goes well beyond COVID into some of our most prevalent diseases,...

    In 1989, when Katalin Karikó submitted her first grant application to develop messenger RNA-based gene therapy, she k...

    September 20, 2021
  • Stem cells could be key to osteoporosis treatment

    Researchers find a way to rejuvenate isolated bone marrow stem cells, paving the way for possible...

    Aging stem cells might hold clues for treating osteoporosis, according to new research. As we get old, our bones b...

    September 15, 2021
  • How do you get your hearts to beat together? Tell a great story

    The pace of a story can synchronise listener’s hearts

    The performance may be breathtaking. A plot twist can make your heart leap! So it’s probably to be expected that thos...

    September 15, 2021
  • Underwater hotels for homeless seahorses

    Researchers have released hundreds of baby endangered seahorses in man-made ocean hotels to boost...

    Wild storms have wrecked seahorse habitats across the Australian east coast. Vast volumes of sand smothered the soft ...

    September 13, 2021
  • Chronic pain can hurt your feelings

    Living with persisting pain can disrupt the way your brain processes emotions.

    For too long, people living with chronic pain have been stigmatised for not coping with the negative emotions associa...

    September 10, 2021
  • Promising pain relief

    Australian researchers have discovered a class of compounds that are safe and effective analgesic...

    Chronic pain is a global health burden. In Australia, it is estimated that over 3.4 million people suffer from persis...

    September 9, 2021
  • Pain and the brain: Closing the gap between modern pain science and clinical practice

    It may seem like the two go hand in hand, but there is still a divide.

    Statistics show that chronic pain affects 3.4 million Australians - that's almost 14% of the population. But while pa...

    September 1, 2021
  • Is this the new normal? There’s mixed news in the latest breaking research on vaccines, the Delta variant and immunity from COVID-19

    Vaccines have been touted as the way out of this pandemic – and no one doubts they save lives and...

    As vaccines rolled out early this year, COVID-19 cases began to dwindle in some countries – fomenting hopes that this...

    August 27, 2021
  • COVID-19 and women

    Latest research reveals that COVID-19 poses particular risks for women.

    The COVID-19 pandemic has hit men and women differently. While men are more vulnerable to severe acute COVID-19 infec...

    August 27, 2021
  • COVID-19 vaccines for young children?

    Vaccine makers are undertaking COVID-19 vaccine trials in young children. Is it safe and necessary?

    A surge of COVID-19 cases among young children and teenagers means vaccinating children could offer them direct prote...

    August 18, 2021
  • Need to get rid of COVID? There’s a model for that…

    How do we best use our supplies of COVID-19 vaccines during an outbreak such as the current one i...

    Talk about timing. In late April, a research paper published in the journal Vaccine took the population of New Sou...

    July 30, 2021
  • How to shield our most vulnerable from COVID-19

    Just isolating the elderly is not enough to reduce hospitalisation and mortality.

    When the COVID-19 pandemic began to spread and kill hundreds of thousands globally in 2020, governments’ priority was...

    July 27, 2021
  • Anglo or Asian? The only good news from Australia’s sluggish vaccine rollout: the chance to learn from other countries’ reopening experiments.

    What do the UK’s and Singapore’s different approaches mean for our COVID reopening? International...

    After spending most of the past 18 months in and out of lockdown, the UK is planning a full reopening despite the soa...

    July 16, 2021
  • Is a quarter-dose of Moderna vaccine enough?

    Diluting mRNA vaccine still elicits significant immune response and might address world’s shortage.

    According to a preprint study, two shots of the Moderna COVID-19 vaccine, each containing only one-quarter of the sta...

    July 14, 2021
  • Australian made mRNA vaccines

    For months, experts have been calling for mRNA to be manufactured onshore. It’s not too late to k...

    Last September, German biotech company BioNTech bought a production site from Swiss drugs giant Novartis to manufactu...

    July 9, 2021
  • Is COVID-19 becoming a childhood disease?

    More children are being infected by the Delta variant.

    In the early days of the COVID-19 pandemic, it became apparent that this coronavirus affected older people more sever...

    July 8, 2021
  • To lockdown or not to lockdown?

    We could be learning from our own experience, experts say.

    Australia does not have a national strategy to deal with hotel quarantine breaches and consequent outbreaks.  Quee...

    July 5, 2021
  • We (really) need to talk about reopening…

    Are our leaders looking at the scientific evidence or the ballot box?

    Australia has been one of the world’s COVID-19 success stories, with a total of just over 30,000 cases and 910 deaths...

    July 2, 2021
  • Smart masks to detect COVID-19

    Biosensors woven into your mask could detect if you have been infected with COVID-19.

    Researchers from the Wyss Institute for Biologically Inspired Engineering at Harvard University and the Massachusetts...

    July 2, 2021
  • Delta is keeping Australia on alert

    The fast-spreading SARS-CoV-2 variant named Delta can transmit through “fleeting contact”.

    This article was first published on 22nd June 2021. Up-to-date information on the current outbreak in NSW may be foun...

    June 28, 2021
  • AstraZeneca COVID vaccines now sit on the shelf. What next?

    New blood clot cases have led to a further revision of rules around Australia’s only locally prod...

    Yesterday, the Australian Technical Advisory Group on Immunisation (ATAGI) revised its recommendations for the AstraZ...

    June 18, 2021
  • What are T cells and how do they help immunity?

    T cells might play a crucial role in COVID-19 vaccines efficacy against variants.

    COVID-19 vaccines currently rolled out worldwide induce a potent antibody response, protecting vaccinated people agai...

    June 17, 2021
  • How far can SARS-CoV-2 travel into the airways?

    A mathematical model shows it reaches deep into our lungs, and more to the right than the left.

    SARS-CoV-2 is transmitted by aerosols – tiny particles delivered through coughing, sneezing and talking that remain s...

    June 15, 2021
  • Developing vaccines for forgotten flaviviruses

    While COVID-19 continues to dominate headlines, flaviviruses have silently affected thousands wor...

    In early 2015, several people presented to hospitals in north-eastern Brazil with mild fever, rashes, conjunctivitis,...

    June 11, 2021
  • Surviving aged care in a pandemic

    With the Melbourne lockdown set to lift, many questions remain around vaccine rollout in aged care.

    On 27 May Victoria entered its fourth lockdown after yet another COVID-19 quarantine breach. A few days into the lock...

    June 10, 2021
  • New variants on the rise

    Fast emerging and spreading of potentially more dangerous SARS-CoV2 variants keep threatening the...

    In the past few days, two main variants first identified in India have crowded Australian newspapers' headlines. Thes...

    June 4, 2021
  • It’s a small, silent, stable world

    Creating the conditions to see things at an atomic level requires a special brand of engineering....

    At 10 Innovation Walk on Monash University’s Clayton Campus, in Melbourne, there’s a building like no other in Austra...

    May 28, 2021
  • Remember the flu?

    Influenza is at a record low in Australia but getting a flu vaccine is still a good idea.

    An astonishingly low number of influenza cases have been recorded in the past 12 months. From the start of the year t...

    May 28, 2021
  • Could a nasal spray protect you from COVID-19?

    Heparin might work as a short-term protective shield against COVID-19 when squirted up the nose b...

    Researchers from the University of Melbourne have observed that spraying heparin on epithelial cells stops SARS-CoV-2...

    May 25, 2021
  • How do we vaccinate the world?

    It’s going to require a global effort – from which much of the globe is excluded.

    Much as isolated Australians might like to pretend otherwise, COVID-19 continues to fill mortuaries across the world....

    May 21, 2021
  • Can I get two different COVID-19 vaccines?

    Combining different COVID-19 shots could speed immunisation campaigns. Would it be safe and effec...

    A UK study launched in February is comparing combinations of the AstraZeneca and Pfizer vaccines in a bid to ease the...

    May 20, 2021
  • Hesitant about COVID-19 vaccines? You’re not alone

    People have the right to ask questions, experts say: but the Australian Government really needs t...

    The latest data from the COVID-19 vaccine preparedness study see Australians’ intention to get a COVID-19 vaccine, po...

    May 19, 2021
  • I’m pregnant. Should I get a COVID-19 vaccine?

    Without enough women in clinical trials, it is hard to say.

    Getting any type of vaccination is a big decision when pregnant – but the more data we have the better informed we ca...

    May 12, 2021
  • One billion doses reached

    Global vaccine rollout is underway, but disparity might not allow us to get the pandemic under co...

    About a week ago, the world reached a remarkable milestone. Only 14 months after the World Health Organization (WHO) ...

    May 10, 2021
  • COVID-19 breaks out in Timor-Leste

    COVID-19 and severe floods are putting Timor-Leste’s health care system under increasing pressure.

    Australia’s near neighbour, and former Portuguese colony with a population of 1.2 million, Timor-Leste has remained r...

    May 7, 2021
  • Inside ATAGI, Australia’s vaccine advisory group

    Who are the experts behind Australia’s COVID-19 vaccine rollout and how did they decide the process?

    When the COVID-19 pandemic started spreading beyond China’s borders and reached Australia early in 2020, the Australi...

    May 7, 2021
  • Do we need to vaccinate kids against COVID-19?

    Early results in from first clinical trials on children.

    When we think of vaccination, we generally think of children because that is when we usually get immunised. With COVI...

    April 28, 2021
  • Opioids and overdose risk

    Co-prescription of opioid antagonists could reduce fatal overdose risk, experts say.

    People who live with ongoing pain face daily challenges in getting on with their lives despite the pain. Among the ma...

    April 26, 2021
  • COVID-19 vaccine hesitancy on the rise

    Community engagement is key, experts say.

    A recent survey from the Melbourne Institute found that, in the past four months, Australians’ willingness to get vac...

    April 23, 2021
  • Australian mRNA vaccines?

    A funding boost should see us manufacturing mRNA vaccines onshore in coming years.

    Yesterday the Victorian Government announced a $50 million investment to set up a facility to develop and manufacture...

    April 22, 2021
  • Vaccine efficacy on variants

    How do we know if current vaccines will be effective against new variants?

    The emerging of new COVID variants around the globe is raising concerns on whether these might blunt the efficacy of ...

    April 16, 2021
  • How do COVID variants emerge?

    Evidence suggests that people with weak immune systems may be accelerating mutations.

    Since its first appearance in Wuhan, China, SARS-CoV2 has been acquiring random mutations. In recent months several n...

    April 15, 2021
  • AstraZeneca vaccine: clot or not?

    The AstraZeneca vaccine’s rollout has now been limited. Is there a clear answer as to whether it ...

    In mid-March, several European countries paused the distribution of the AstraZeneca COVID-19 vaccine following report...

    April 9, 2021
  • It’s worth re-engineering the clamp

    UQ’s COVID-19 vaccine trial demonstrated the benefits of the molecular clamp technology.

    The Australian COVID-19 vaccine developed by the University of Queensland was abandoned last December after participa...

    April 6, 2021
  • Immunosuppressants and COVID-19

    The divergent effect of immunosuppressive drugs in COVID-19 infection.

    Immunosuppressant drugs commonly used for autoimmune diseases such as rheumatoid arthritis, psoriasis, and Crohn’s di...

    April 6, 2021
  • COVID-19 vaccines and cancer

    Cancer patients are among the most vulnerable to COVID-19 infection. Are vaccines safe and effect...

    People with cancer are at a higher risk of developing severe infection when they catch the SARS-CoV-2 virus. That’s b...

    April 1, 2021
  • Update on AstraZeneca and blood clots

    German researchers might have found the link between the COVID-19 vaccine and unusual cases of bl...

    The Australian Technical Advisory Group on Immunisation (ATAGI) – the group of experts that advises the government on...

    March 26, 2021
  • Common drug makes COVID worse

    A treatment for inflammatory bowel disease might dampen COVID-19 immune response.

    A new study, published today in the BMJ, showed that a commonly prescribed inflammatory bowel disease (IBD) drug call...

    March 24, 2021
  • Halts to AstraZeneca vaccine in Europe: latest

    Are European countries overreacting, or is there a cause for concern?

    On Monday, Germany, France and Italy joined a group of other European countries that had temporarily stopped administ...

    March 19, 2021
  • South African variant yet more concerning

    Study on AstraZeneca vaccine’s efficacy against B.1.351 shows “disappointing” results.

    Early in February, the South African government suspended the AstraZeneca vaccine rollout after a small-scale trial f...

    March 17, 2021
  • Equitable vaccine access for all

    It’s not just idealism: equal access makes everyone COVID safer.

    The coronavirus pandemic has claimed the lives of more than 2.6 million people globally and disrupted everyone’s live...

    March 15, 2021
  • Pain education could end the opioid crisis

    Training clinicians makes them less likely to prescribe opioids in emergency departments.

    Low back pain is today a leading cause of disability worldwide. It occurs across all ages, socioeconomic levels and c...

    March 11, 2021
  • Global pandemic needs a global plan

    While Australia and Europe squabble over vaccine doses, parts of the world are abandoned.

    On Thursday, Italy blocked the export of 250,000 doses of the AstraZeneca vaccine bound for Australia. With support f...

    March 6, 2021
  • Determined science

    A multi-skilled, international team conducted the detailed research into the Folbigg family’s gen...

    In 2003, Kathleen Folbigg was convicted of killing her four young children, who died suddenly and unexpectedly in the...

    March 5, 2021
  • The jab is jumpin’

    Australia’s vaccine rollout is underway. Are we on track?

    The first 300,000 doses of the Oxford/AstraZeneca jab landed at Sydney airport last Sunday. The AstraZeneca vaccin...

    March 3, 2021
  • South Africa concern

    Questions over AstraZeneca vaccine’s efficacy against new variant.

    South Africa has suspended the rollout of the AstraZeneca vaccine after a small-scale trial found that the vaccine of...

    February 10, 2021
  • What’s so scary about the UK variant?

    Are new COVID-19 strains a more dangerous threat?

    The new highly infectious variant of SARS-CoV-2 first identified in the United Kingdom last December has landed in Au...

    January 9, 2021

Read science facts, not fiction...

There’s never been a more important time to explain the facts, cherish evidence-based knowledge and to showcase the latest scientific, technological and engineering breakthroughs. Cosmos is published by The Royal Institution of Australia, a charity dedicated to connecting people with the world of science. Financial contributions, however big or small, help us provide access to trusted science information at a time when the world needs it most. Please support us by making a donation or purchasing a subscription today.